Medtronic sidesteps whistleblower suit
This article was originally published in The Gray Sheet
Executive Summary
Gilligan v. Medtronic dismissed by U.S. Court of Appeals for the Sixth Circuit because the plaintiff's grounds for allegations were publicly disclosed already and thus exempt from the False Claims Act, Washington Legal Foundation reports April 13. WLF had filed a brief supporting Medtronic and urging dismissal on the grounds that the Supreme Court's 2001 Buckman decision precluded all fraud-on-FDA claims. Attorneys Louis Gilligan and Gregory Utter attempted to sue Medtronic on behalf of the U.S. government, citing malfunctions with two pacemaker leads that have been off the market for more than a decade...